TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,344,062 | +283.8% | 160,773 | +1040.2% | 0.00% | +300.0% |
Q2 2023 | $350,244 | +37.8% | 14,100 | -16.6% | 0.00% | -75.0% |
Q1 2023 | $254,176 | -69.8% | 16,900 | -91.5% | 0.00% | -82.6% |
Q2 2022 | $842,000 | +419.8% | 198,233 | +1098.5% | 0.02% | -36.1% |
Q1 2020 | $162,000 | -52.1% | 16,540 | -45.6% | 0.04% | +63.6% |
Q4 2019 | $338,000 | – | 30,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
Antara Capital LP | 900,000 | $3,825,000 | 0.16% |